Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,411 across all filing types
Latest filing 2026-06-01 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Admission of Further Securities to Trading
Share Issue/Capital Change Classification · 85% confidence The document is a short RNS announcement titled “Notification of Admission of Further Securities to Trading” indicating that AstraZeneca is admitting newly issued ordinary shares (14,120 shares) under its employee share schemes to trading on the London Stock Exchange. It details the number of securities issued, total in issue, admission dates, and fungibility. This is an announcement of a share issuance/capital change event, matching the definition of Share Issue/Capital Change (SHA).
2026-06-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is an RNS announcement titled “Total Voting Rights,” reporting the number of issued ordinary shares and total voting rights in accordance with UK FCA Disclosure and Transparency Rule 5.6.1. It is a formal announcement of voting rights, not a report or financial statements. This fits the Declaration of Voting Results & Voting Rights Announcements category.
2026-06-01 English
ADMISSION OF FURTHER SECURITIES TO TRADING
Regulatory Filings
2026-06-01 English
TOTAL VOTING RIGHTS
Regulatory Filings
2026-06-01 English
IMFINZI APPROVED IN US FOR EARLY BLADDER CANCER
Regulatory Filings
2026-05-29 English
Imfinzi approved in US for early bladder cancer
Regulatory Filings Classification · 94% confidence The document is an RNS-distributed press release announcing FDA approval of a drug (Imfinzi) based on clinical trial results. It contains no financial statements, voting results, management changes, or report attachments—it is a regulatory announcement/press release. It fits the Regulatory Filings (RNS) catch-all category.
2026-05-29 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.